116 related articles for article (PubMed ID: 34881777)
1. LASP-1 interacts with ErbB2 in ovarian cancer cells.
Sidhanth C; Bindhya S; Shabna A; Krishnapriya S; Manasa P; Nagare RP; Joshua T; Sneha S; Murhekar K; Ganesan TS
Biochem J; 2022 Jan; 479(1):23-38. PubMed ID: 34881777
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation.
Grunewald TG; Kammerer U; Winkler C; Schindler D; Sickmann A; Honig A; Butt E
Br J Cancer; 2007 Jan; 96(2):296-305. PubMed ID: 17211471
[TBL] [Abstract][Full Text] [Related]
3. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.
Duvall-Noelle N; Karwandyar A; Richmond A; Raman D
Oncogene; 2016 Mar; 35(9):1122-33. PubMed ID: 25982273
[TBL] [Abstract][Full Text] [Related]
4. Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma.
Grunewald TG; Kammerer U; Kapp M; Eck M; Dietl J; Butt E; Honig A
BMC Cancer; 2007 Oct; 7():198. PubMed ID: 17956604
[TBL] [Abstract][Full Text] [Related]
5. Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion.
Gao W; Han J
Oncol Res; 2017 Jul; 25(6):879-886. PubMed ID: 27938497
[TBL] [Abstract][Full Text] [Related]
6. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
[TBL] [Abstract][Full Text] [Related]
7. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
Wang H; Li W; Jin X; Cui S; Zhao L
Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
[TBL] [Abstract][Full Text] [Related]
8. Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.
Frietsch JJ; Grunewald TG; Jasper S; Kammerer U; Herterich S; Kapp M; Honig A; Butt E
Br J Cancer; 2010 May; 102(11):1645-53. PubMed ID: 20461080
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.
Jeong J; Choi J; Kim W; Dann P; Takyar F; Gefter JV; Friedman PA; Wysolmerski JJ
J Biol Chem; 2019 Jan; 294(3):887-901. PubMed ID: 30463939
[TBL] [Abstract][Full Text] [Related]
10. Acquired substrate preference for GAB1 protein bestows transforming activity to ERBB2 kinase lung cancer mutants.
Fan YX; Wong L; Marino MP; Ou W; Shen Y; Wu WJ; Wong KK; Reiser J; Johnson GR
J Biol Chem; 2013 Jun; 288(23):16895-16904. PubMed ID: 23612964
[TBL] [Abstract][Full Text] [Related]
11. Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions.
Mihlan S; Reiß C; Thalheimer P; Herterich S; Gaetzner S; Kremerskothen J; Pavenstädt HJ; Lewandrowski U; Sickmann A; Butt E
Oncogene; 2013 Apr; 32(16):2107-13. PubMed ID: 22665060
[TBL] [Abstract][Full Text] [Related]
12. HBX protein promotes LASP-1 expression through activation of c-Jun in human hepatoma cells.
You H; Kong F; Zhou K; Wei X; Hu L; Hu W; Luo W; Kou Y; Liu X; Chen X; Zheng K; Tang R
J Cell Physiol; 2018 Sep; 233(9):7279-7291. PubMed ID: 29600594
[TBL] [Abstract][Full Text] [Related]
13. Investigating lasp-2 in cell adhesion: new binding partners and roles in motility.
Bliss KT; Chu M; Jones-Weinert CM; Gregorio CC
Mol Biol Cell; 2013 Apr; 24(7):995-1006. PubMed ID: 23389630
[TBL] [Abstract][Full Text] [Related]
14. LIM and SH3 domain protein 1 (LASP-1) overexpression was associated with aggressive phenotype and poor prognosis in clear cell renal cell cancer.
Yang F; Zhou X; Du S; Zhao Y; Ren W; Deng Q; Wang F; Yuan J
PLoS One; 2014; 9(6):e100557. PubMed ID: 24955835
[TBL] [Abstract][Full Text] [Related]
15. An insertion mutation of ERBB2 enhances breast cancer cell growth and confers resistance to lapatinib through AKT signaling pathway.
Yang ZY; Yang L; Xu CW; Wang XJ; Lei L
Biol Open; 2020 Jan; 9(1):. PubMed ID: 31980423
[TBL] [Abstract][Full Text] [Related]
16. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway.
Sun W; Guo L; Shao G; Liu X; Guan Y; Su L; Zhao S
Oncol Rep; 2017 Jan; 37(1):341-347. PubMed ID: 27840958
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia/HIF1α induces lapatinib resistance in ERBB2-positive breast cancer cells via regulation of DUSP2.
Karakashev SV; Reginato MJ
Oncotarget; 2015 Feb; 6(4):1967-80. PubMed ID: 25596742
[TBL] [Abstract][Full Text] [Related]
18. Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors.
Xia W; Liu Z; Zong R; Liu L; Zhao S; Bacus SS; Mao Y; He J; Wulfkuhle JD; Petricoin EF; Osada T; Yang XY; Hartman ZC; Clay TM; Blackwell KL; Lyerly HK; Spector NL
Mol Cancer Ther; 2011 Aug; 10(8):1367-74. PubMed ID: 21673090
[TBL] [Abstract][Full Text] [Related]
19. The cytoskeletal protein LASP-1 differentially regulates migratory activities of choriocarcinoma cells.
Segerer SE; Bartmann C; Kaspar S; Müller N; Kapp M; Butt E; Kämmerer U
Arch Gynecol Obstet; 2016 Feb; 293(2):407-14. PubMed ID: 26232936
[TBL] [Abstract][Full Text] [Related]
20. BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib.
Godinho MF; Wulfkuhle JD; Look MP; Sieuwerts AM; Sleijfer S; Foekens JA; Petricoin EF; Dorssers LC; van Agthoven T
Br J Cancer; 2012 Sep; 107(6):947-55. PubMed ID: 22892392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
